2Dumortier B, Nosbaurn A, Ponvert C, et al. Measles-Mumps-Rubella vaccination of an egg-allergic child sensitized to gelatin[J]. Arch Ped- iatr, 2013, 20(8):867-870.
3Heijstek MW, Kamphuis S, Armbrust W, et al. Effects of the live atten- uated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial[J]. JA- MA, 2013,309(23):2449-2456.
4Mahamud A, Masunu-Faleafaga Y, Walls L, et al. Seroprevalence of measles, mumps and rubella among children in American Samoa, 2011, and progress towards West Pacific Region goals of elimination [J]. Vaccine, 2013.31 (36):3683-3687.
5McLean HQ, Fiebelkom AP, Temte JL, et al. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary rec- ommendations of the Advisory Committee on Immunization Practices (ACIP)[J]. MMWR Recomm Rep, 2013, 62(4): 1-34.
6Waaijenborg S, Hahn~ S J, Mollema L, et al. Waning of maternal antib- odies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage [J]. J Infect Dis, 2013, 208(1): 10-16.
7Eckerle I, Keller-Stanislawski B, Santibanez S, et al. Nonfebrile seizur- es atter mumps, measles, rubella, and varicella-zoster virus combinati- on vaccination with detection of measles virus RNA in serum, throat, and urine[J]. Clin Vaccine Immunol, 2013, 20(7): 1094-1096.
8Gentile I, Bravaccio C, Bonavolta R, et al. Response to measles-mum- ps-rubella vaccine in children with autism spectrum disorders [J].n Vivo, 2013, 27(3):377-382.
9Sniadack DH, Orenstein WA. A measles eradication goal is upon us; can rubella and congenital rubella syndrome be far behind?[J]. Vacci- ne, 2013, 31 (24):2659-2660.
10Mrozek-Budzyn D, Kie tyka A, Majewska R, et al. Measles, mumps and rubella (MMR) vaccination has no effect on cognitive developm- ent in children - the results of the Polish prospective cohort study[J]. Vaccine, 2013, 31 (22):2551-2557.
